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Background: In many countries, Alzheimer’s disease (AD) has gradually become a 
relevant disease in elderly populations. The aim of this study was to analyse trends of 
mortality caused by AD in the 28 member countries in the European Union (EU) over the 
last two decades. 
Methods: We extracted data for AD deaths for the period 1994-2013 in the EU from the 
Eurostat and World Health Organization database. Age-standardised mortality rates per 
100,000 were computed. Joinpoint regression was used to analyse the trends and compute 
the annual percent change (APC) in the EU as a whole and by country. Analyses by 
gender and by European regions were conducted. 
Results: Throughout the study period, mortality from AD has risen in the EU. Most of 
the countries showed upward trends, with the sharpest increases in Slovakia, Lithuania 
and Romania. In men and women, we recorded a 4.7% and 6.0% statistically significant 
increase in mortality rates in the whole EU, respectively. Several countries showed 
changing trends during the study period. According to the regional analysis, Northern and 
Eastern countries showed the steepest increases, while in the latter years in Western 
countries mortality has declined. 
Conclusions: Our findings provide evidence that AD mortality has increased in the EU, 
especially in Eastern and Northern European countries and in the female population. Our 
results could be a reference for the development of primary prevention policies. 
 
Keywords: Alzheimer’s disease; Mortality; Trends; European Union; Joinpoint analysis 
  
Introduction 
Alzheimer’s disease (AD) is defined by the World Health Organization (WHO) 
as a degenerative cerebral disease of unknown etiology, with characteristic 
neuropathological and neurochemical features [1]. 
With the progressive increase in life expectancy, AD has become an increasing 
public health issue. In 2013, the Global Burden of Disease Study found that AD was one 
of the top 50 global causes of years of life lost which experienced a more pronounced 
increase in the past years [2], and it has been estimated the disease will be the seventh 
cause of death in high income countries in the year 2030 [3]. 
Previous studies described increasing trends in mortality from AD in the United 
States, where the mortality rate rose from 45.3 in 1999 to 50.0 per 100,000 in 2008 [4], 
and in Canada, where the crude mortality rate for men and women increased from 10.1 
to 11.5 per 100,000 and 24.4 to 25.4 per 100,000, respectively, between 2004 and 2011 
[5]. 
However, to date, no studies have been conducted at a European level using a 
consistent methodology, estimating significant changes in trends. Therefore, the aim of 
this study was to analyse trends of mortality caused by AD in the European Union (EU) 
in the period 1994-2013. 
Methods 
Data from men and women over 50 years of age from the 28 member countries of 
the EU in the period 1994-2013 were extracted from the statistical office of the EU 
(Eurostat) (http://ec.europa.eu/eurostat/data/database) [6]. The WHO database was used 
when data were not available (http://data.euro.who.int/dmdb/) [7], extracting data from 
Belgium (2000-2002), Denmark (2010), Germany (1998-2008), France (2011), Croatia 
(1995-1998), The Netherlands (1996-2006), Poland (1999-2004), and Slovakia (1994-
1995). Databases were updated in April 2016 and December 2015, respectively. Both 
databases receive data from each country’s statistical authorities, and no further analyses 
are conducted. Thus we assume data do not differ substantially, and do not have a 
significant effect on the results. 
During the study period, two different revisions of the International Classification 
of Diseases (ICD) were used (ICD 9th and 10th revisions). AD deaths were recorded 
according to the ICD-9 code 331.0 and ICD-10 code G30. 
Estimates of resident population, based on official censuses, were also extracted 
from the Eurostat database (updated on April 2016) [6]. Due to the study design, no 
approval by an institutional review board was needed. 
The 28 EU member countries and their available data included: Belgium (1998-
2013), Bulgaria (2005-2013), Czech Republic (1994-2013), Denmark (1994-2013), 
Germany (1998-2013), Estonia (1997-2013), Ireland (1997-2013), Greece (1994-2013), 
Spain (1994-2013), France (metropolitan) (1994-2011), Croatia (1995-2013), Italy 
(2001-2003, 2006-2013), Cyprus (2004-2013), Latvia (1996-2013), Lithuania (1994-
2013), Luxembourg (1998-2013), Hungary (1994-2013), Malta (1995-2011, 2013), the 
Netherlands (1996-2013), Austria (1994-2013), Poland (1999-2013), Portugal (1994-
2000, 2002-2013), Romania (1999-2013), Slovenia (1995-2013), Slovakia (1994-2013), 
Finland (1996-2013), Sweden (1994-2013), and the United Kingdom (1994-2013). 
Unfortunately, data for one or more calendar years were missing from a few countries. 
No extrapolation was made for missing data. We assume that in those countries with less 
missing data, trends would not notably vary. Conversely, in those countries with more 
missing data, results could have been affected to a certain extent, and should be 
interpreted carefully. 
From the matrices of certified death and resident population, age-standardised 
mortality rates per 100,000 for each 5-year age group (from 50-54 to 85 and more) and 
calendar period for men and women were computed, using the direct method and based 
on the 2013 European Standard Population.  
We also conducted an analysis to assess regional mortality trends, distinguishing 
four European regions: Northern (Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, 
Sweden, and the United Kingdom), Southern (Croatia, Cyprus, Greece, Italy, Malta, 
Portugal, Slovenia, and Spain), Eastern (Bulgaria, Czech Republic, Hungary, Poland, 
Romania, and Slovakia), and Western Europe (Austria, Belgium, France, Germany, 
Luxembourg, and the Netherlands). 
We used the Joinpoint regression software (version 4.2.0.2) provided by the 
Surveillance Research Program of the USA National Cancer Institute to analyse 
significant changes in mortality trends. This analysis identifies inflexion points (called 
“joinpoints”) at which there is a significant change in the linear slope of the trend [8]. The 
number and location of significant joinpoints for each country were determined using a 
log-linear model. We computed the estimated annual percent change (APC) and 
corresponding 95% confidence intervals (95% CIs), which describes the magnitude of 
change for each of the identified trends. In this model, age-standardised mortality rates 
were used as the dependent variable, and the year of death as the independent variable. In 
all analyses, a p value lower than 0.05 was regarded as statistically significant. 
Results 
Between 1994 and 2013, the number of recorded deaths from AD in the EU 
increased steadily from 41,255 (13,508 men and 27,747 women) to 86,822 (26,974 men 
and 59,848 women). 
Overall age-standardised mortality rate increased from 28.18 to 45.19 per 100,000. 
In 1994, the highest rates were found in France (20.58 per 100,000), and the lowest in 
Lithuania (0.43 per 100,000). In 2013, Finland had the highest mortality rate (278.92 per 
100,000), while the lowest were observed in Malta and Latvia (below 5 per 100,000). 
(Table S1) 
According to our findings, during the 2004-2013 period the entire EU showed a 5.6% 
statistically significant increase, with no identifiable joinpoints. Mortality rates rose over 
the last two decades in 26 countries throughout the EU. Slovakia and Romania had the 
biggest increases (APC=26.0% and APC=22.7%, respectively), while Luxembourg 
(APC=1.2%) and Latvia (APC=2.8%) showed the slightest increases. Only in Malta 
(APC=-4.1%) and Germany (APC=-0.4%) were declining trends observed. 
Trends of mortality from AD by gender 
Age-standardised mortality rates for men are presented in Table S2. In 1994, the 
highest rates were observed in France, Spain and Czech Republic (over 10 per 100,000), 
and the lowest in Lithuania, Slovakia, Greece and Hungary (below 2 per 100,000). In 
2013, Finland had the highest male rates (270.02 per 100,000), while the lowest were 
found in Malta, Greece and Bulgaria (below 6 per 100,000). 
Throughout the EU, men showed a statistically significant increase in mortality 
(APC=4.7%), with no joinpoints observed. Mortality rates between 1994 and 2013 rose 
in 25 countries. Slovakia, Romania and Lithuania had the largest increases, while for 
Poland, Greece and Belgium we observed less pronounced increases. In contrast, only 
Germany, Malta and Luxembourg showed an overall downward trend. (Table 1) 
For eleven countries which had an overall upward trend (Hungary, Lithuania, 
Romania, Greece, Italy, Sweden, Croatia, Portugal, the United Kingdom, Spain, and 
Denmark) APCs peaked, increasing at a lower rate or decreasing thereafter. For three 
countries (Austria, Slovakia and Czech Republic) we observed fluctuating mortality 
trends, with non-significant decreases, followed by pronounced increases. 
For women, the highest rates in 1994 were recorded in France, Spain and Czech 
Republic (over 14 per 100,000), and the lowest in Slovakia and Lithuania (below 1 per 
100,000). In 2013, we observed in Finland the highest female rate (over 280 per 100,000), 
and the lowest in Malta, Latvia and Bulgaria (below 7 per 100,000). (Table S3) 
Among European women, we recorded a 6.0% steady and statistically significant 
increase, without identifying any joinpoints. Mortality from AD rose in 26 countries. The 
most pronounced increases were observed in Slovakia, Romania and Lithuania, while 
Latvia and Luxembourg showed the smallest increases. In Germany rates levelled off, 
and only Malta showed a declining trend. (Table 2) 
In twelve countries with an overall upward trend (Slovakia, Romania, Hungary, 
Sweden, Slovenia, Denmark, France, Italy, Poland, Portugal, Spain, and the United 
Kingdom), APCs peaked and continued increasing at a lower rate. In Latvia and 
Luxembourg, after the APC peaked we observed a declining trend, and increases 
thereafter. The Czech Republic, after a decreasing trend, showed the steepest increases in 
the latter years of the study. 
Trends for both men and women are shown graphically in Figure 1. Except for the 
Czech Republic, Finland, Hungary, Latvia, Lithuania, the Netherlands, and Romania 
trends were more pronounced in women than in men. 
Trends of mortality from AD by region 
Results from the regional mortality trends analysis showed the sharpest increase in 
Northern and Eastern Europe. In Western Europe we observed an overall slight increase, 
and in the period 2009-2013 a statistically significant declining trend, during the same 
period, in Eastern Europe a pronounced increase was recorded. Since the mid 2000s, in 
Southern countries rates have levelled off. (Table 3) 
Discussion 
The present updated analysis of mortality from AD in the EU showed overall upward 
trends in both sexes over the past two decades. The largest increases were found in 
Slovakia, Romania, and Lithuania. In Finland we observed the highest mortality rates, 
with a steady increase over the study period. Mortality rates levelled off or declined for 
only two countries, Germany and Malta. 
Most of the countries showed increasing mortality trends for both genders. We 
compared our findings with previous studies. According to the findings of Desesquelles 
and colleagues [9], in France mortality has been increasing since 1985, which is consistent 
with our results. An Italian study also showed evidence of an upward trend in the period 
1985-2003 in this country, with the steepest increases in the latter years [10]. We only 
analysed available data in the 2000s, when we also observed a pronounced increase in 
mortality rates. In England and Wales, mortality rates experienced an 8-fold increase in 
men and 12-fold increase in women between 1985 and 2004 [11]. According to our 
findings, the United Kingdom (which also included Scotland and North Ireland) also 
showed rising trends for both sexes, especially in women. 
Economic development and improvement of social conditions over the last decades 
have led to an increase in life expectancy [12], which might explain the increasing trends 
in mortality from age-related diseases, especially in Eastern countries (Slovakia, 
Lithuania, Slovenia, Romania, Hungary), where we observed the lowest mortality rates 
in the 1990s. 
Several Northern European countries also showed pronounced increasing trends, 
presumably due not only to the progressive ageing of their population, but also to other 
factors. Studies have demonstrated evidence that APOE Ɛ4 allele frequencies, a well-
studied risk factor for AD [13], are higher in Northern countries [14, 15]. 
Although it might be thought that increasing mortality rates could be attributed to 
better diagnostics, Hallberg [16] rejected this idea in Sweden, and remarked on the 
contribution of environmental factors. However, we cannot discard that better diagnostics 
and increased awareness of the condition by physicians could explain the increase in 
mortality rates in other countries. 
In many countries, the APC peaked in the early years of the study, when most of the 
countries implemented ICD-10. Previous studies found a 55% increase in AD recorded 
deaths when classified by ICD-10 instead ICD-9 [17], due to the inclusion of pre-senile 
dementia and a lax criterion of imputation to any mention of AD [18], which could be the 
reason why mortality rates rose in this period. Posterior lower increases or declining 
trends could be attributed to improvements in health services and prevention policies 
addressing modifiable risk factors. Norton and colleagues [19] showed that in Europe a 
10% reduction per decade of the prevalence of seven modifiable risk factors would result 
in a 9.1% reduction of the prevalence of AD in the future. 
In Germany, mortality rates in men declined, while in women they levelled off. 
Surprisingly, its population is one of the oldest in the entire EU, but this was not reflected 
in rising mortality trends. Previous studies described decreasing trends in dementia 
prevalence between 2007 and 2009, suggesting the reason for these trends might be 
protective factors (better education, economic development) related to the non-war period 
of the 20th century [20]. We also hypothesised that, due to the characteristics and progress 
of the disease, which might lead to other underlying causes of death, mortality from AD 
has possibly been underreported [21,22]. 
Cyprus and Malta were the countries with the smallest populations, and we also 
observed low mortality figures. It must be taken into account that our results, which 
showed rising and declining trends, respectively, could be affected by the effect of their 
small populations. 
It is worth noting that, because of the low rate of recording dementia as the cause of 
death, mortality data were not useful in exploring geographical variation and time trends 
[23,24]. This fact may have contributed to an underestimation of the real AD mortality 
observed in this study. 
Our findings showed pronounced mortality trends for women in most of the 
countries. Sex differences in AD have been widely studied and attributed to several 
factors, including genetic, hormonal and social factors, or the longer life expectancy of 
women [25, 26]. 
When we assessed the regional mortality trends, we observed the biggest increases 
in Northern and Eastern Europe. In contrast, in the latter study years in Southern Europe 
mortality rates levelled off, and in Western Europe a declining trend was observed. We 
hypothesised these differences may be due to lifestyle factors (as well as the social and 
genetic factors previously stated), such as a higher adherence to the Mediterranean diet, 
which has been found as a protecting factor for developing AD [27], and associated with 
a lower mortality risk [28]. 
This study has several strengths. To our knowledge, this is the first study analysing 
AD mortality trends in the whole of the EU. Moreover, mortality data were extracted 
from official databases. Our study also has limitations. The main limitation is the lack of 
data from some countries. These databases are updated with data from national statistical 
offices, but in some cases data were not provided for several years. We decided not to 
extrapolate or impute in order to analyse only official data. Another limitation is the 
reflection of the condition as an underlying cause of death, but not as a contributing cause 
of death. 
Conclusion 
In conclusion, we confirm mortality from AD has significantly increased in the EU 
in the last two decades, especially in Eastern and Northern Europe and the female 
population. Consequently, in the upcoming years, the EU will face not only health, but 
also social and economic challenges. Primary prevention policies addressing to 
preventable risk factors are recommendable. The effect of diagnostics or medical 
awareness of the condition deserves further analyses. 
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Table 1. Joinpoint analysis for Alzheimer’s disease mortality trends in men in the European Union, 1994-2013. 
 Total study period Period 1 Period 2 Period 3 
 Years APC (95% CI) Years APC (95% CI) Years APC (95% CI) Years APC (95% CI) 
European Union 2004-2013 4.7* (4.2, 5.3) - - - - - - 
Austria 1994-2013 10.0* (7.7, 12.3) 1994-1999 -3.0 (-11.8, 6.8) 1999-2003 34.3* (8.5, 66.3) 2003-2013 3.5* (0.1, 7.0) 
Belgium 1998-2013 3.8* (3.1, 4.5) - - - - - - 
Bulgaria 2005-2013 10.5* (2.7, 18.8) 2005-2007 48.9 (-15.2, 161.4) 2007-2013 3.3 (-6.1, 13.6) - - 
Croatia 1995-2013 8.7* (5.8, 11.6) 1995-2000 27.8* (10.4, 47.9) 2000-2013 4.3* (0.8, 8.0) - - 
Cyprus 2004-2013 4.5 (-1.1, 10.5) - - - - - - 
Czech Republic 1994-2013 6.0* (3.0, 9.1) 1994-2006 11.2* (6.9, 15.6) 2006-2009 -26.2 (-62.1, 43.7) 2009-2013 40.3* (13.6, 73.1) 
Denmark 1994-2013 10.8* (9.5, 12.1) 1994-2006 13.9* (12.2, 15.6) 2006-2013 4.3* (0.8, 7.9) - - 
Estonia 1997-2013 6.1* (2.9, 9.4) - - - - - - 
Finland 1996-2013 13.7* (12.7, 14.7) 1996-1999 6.6 (-0.9, 14.6) 1999-2007 17.3* (15.0, 19.6) 2007-2013 9.0* (6.3, 11.7) 
France 1994-2011 7.4* (5.8, 9.0) 1994-2003 12.8* (11.4, 14.3) 2003-2011 1.3 (-0.2, 2.9) - - 
Germany 1998-2013 -1.8* (-2.6, -1.0) 1998-2003 1.4 (-0.8, 3.7) 2003-2008 -6.0* (-8.9, -3.0) 2008-2013 2.2 (-0.0, 4.5) 
Greece 1994-2013 3.7 (-0.1, 7.7) 1994-2000 35.1* (24.0, 47.1) 2000-2013 -4.9* (-7.4, -2.4) - - 
Hungary 1994-2013 11.2* (9.4, 13.0) 1994-1996 50.9* (10.3, 106.3) 1996-2013 9.7* (8.5, 10.9) - - 
Ireland 1997-2013 5.2* (3.2, 7.3) - - - - - - 
Italy 2001-2013 4.7* (2.1, 7.4) 2001-2003 33.3* (14.7, 55.0) 2003-2013 1.7* (0.0, 3.3) - - 
Latvia 1996-2013 8.7* (2.8, 15.0) - - - - - - 
Lithuania 1994-2013 23.2* (17.6, 29.1) 1994-1999 81.4* (55.9, 111.2) 1999-2013 12.9* (9.3, 16.5) - - 
Luxembourg 1998-2013 -1.5 (-5.0, 2.1) - - - - - - 
Malta 1995-2013 -5.8* (-10.5, -0.9) - - - - - - 
Netherlands 1996-2013 8.7* (7.3, 10.0) 1996-2011 7.4* (6.5, 8.3) 2011-2013 35.8* (11.7, 65.2) - - 
Poland 1999-2013 3.4* (2.5, 4.3) - - - - - - 
Portugal 1994-2013 11.3* (8.3, 14.3) 1994-2003 24.5* (21.4, 27.7) 2003-2013 0.8 (-1.2, 2.8) - - 
Romania 1999-2013 23.2* (19.6, 26.9) 1999-2004 39.6* (25.7, 55.0) 2004-2013 16.7* (11.8, 21.8) - - 
Slovakia 1994-2013 23.8* (19.6, 28.2) 1994-1996 -24.8 (-66.0, 65.9) 1996-2001 59.8* (24.4, 105.3) 2001-2013 15.2* (9.9, 20.7) 
Slovenia 1995-2013 12.1* (4.7, 20.1) - - - - - - 
Spain 1994-2013 6.5* (4.8, 8.3) 1994-1997 8.2 (-1.0, 18.2) 1997-2001 21.5* (11.2, 32.7) 2001-2013 1.6* (0.5, 2.6) 
Sweden 1994-2013 11.6* (8.9, 14.3) 1994-2001 27.7* (21.1, 34.6) 2001-2013 4.9* (2.4, 7.3) - - 
United Kingdom 1994-2013 7.7* (6.3, 9.1) 1994-1999 3.2 (-2.5, 9.2) 1999-2002 23.4 (-4.2, 58.8) 2002-2013 4.3* (2.5, 6.0) 
APC: Annual percent change; CI: Confidence intervals 
*p<0.05 for change in trend. 
Table 2. Joinpoint analysis for Alzheimer’s disease mortality trends in women in the European Union, 1994-2013. 
 Total study period Period 1 Period 2 Period 3 
 Years APC (95% CI) Years APC (95% CI) Years APC (95% CI) Years APC (95% CI) 
European Union 2004-2013 6.0* (5.3, 6.7) - - - - - - 
Austria 1994-2013 11.4* (9.2, 13.7) 1994-1999 -4.6 (-10.4, 1.7) 1999-2003 37.6* (19.4, 58.6) 2003-2013 5.4* (3.0, 7.7) 
Belgium 1998-2013 4.6* (3.7, 5.5) - - - - - - 
Bulgaria 2005-2013 11.4* (5.7, 17.3) - - - - - - 
Croatia 1995-2013 10.3* (7.2, 13.4) 1995-1997 -10.0 (-43.5, 43.2) 1997-2001 41.4* (12.1, 78.4) 2001-2013 3.4* (0.6, 6.3) 
Cyprus 2004-2013 7.7* (1.1, 14.7) - - - - - - 
Czech Republic 1994-2013 4.0* (1.1, 6.9) 1994-2005 10.4* (6.3, 14.5) 2005-2009 -21.1 (-40.1, 3.9) 2009-2013 37.3* (15.4, 63.4) 
Denmark 1994-2013 12.5* (10.8, 14.2) 1994-2004 18.2* (15.7, 20.8) 2004-2013 6.1* (3.4, 8.8) - - 
Estonia 1997-2013 8.5* (5.5, 11.6) - - - - - - 
Finland 1996-2013 13.0* (12.3, 13.7) 1996-2000 8.2* (2.8, 13.7) 2000-2013 13.9* (13.0, 14.9) - - 
France 1994-2011 8.8* (7.2, 10.5) 1994-2003 14.5* (13.0, 16.0) 2003-2011 2.5* (1.0, 4.1) - - 
Germany 1998-2013 0.2 (-0.4, 0.9) 1998-2002 3.6 (-0.7, 8.2) 2002-2010 -1.6 (-3.3, 0.2) 2010-2013 5.4 (-1.5, 12.8) 
Greece 1994-2013 6.1* (2.6, 9.7) 1994-2000 34.0* (24.4, 44.5) 2000-2013 -1.8 (-4.0, 0.5) - - 
Hungary 1994-2013 9.5* (7.8, 11.3) 1994-1996 61.0* (26.2, 105.3) 1996-2013 7.7* (6.8, 8.6) - - 
Ireland 1997-2013 6.2* (4.7, 7.6) - - - - - - 
Italy 2001-2013 5.6* (3.0, 8.2) 2001-2003 32.2* (10.9, 57.5) 2003-2013 2.7* (0.7, 4.6) - - 
Latvia 1996-2013 1.6 (-1.9, 5.2) 1996-2001 31.5* (11.5, 54.9) 2001-2004 -23.4 (-63.2, 59.8) 2004-2013 3.4 (-3.3, 10.6) 
Lithuania 1994-2013 20.4* (16.2, 24.8) - - - - - - 
Luxembourg 1998-2013 2.8* (1.2, 4.4) 1998-2000 32.2* (4.3, 67.5) 2000-2007 -1.6 (-5.5, 2.4) 2007-2013 5.6* (1.4, 9.9) 
Malta 1995-2013 -3.2 (-7.7, 1.5) - - - - - - 
Netherlands 1996-2013 7.3* (5.8, 8.9) 1996-2000 -0.2 (-7.2, 7.3) 2000-2011 7.4* (5.5, 9.3) 2011-2013 32.8* (5.7, 66.9) 
Poland 1999-2013 4.4* (3.6, 5.3) 1999-2005 7.2* (5.3, 9.1) 2005-2013 2.7* (1.5, 3.9) - - 
Portugal 1994-2013 12.1* (9.1, 15.1) 1994-2003 25.3* (22.8, 27.8) 2003-2013 1.6* (0.0, 3.2) - - 
Romania 1999-2013 22.3* (19.2, 25.5) 1999-2004 37.0* (26.3, 48.5) 2004-2013 16.4* (12.7, 20.4) - - 
Slovakia 1994-2013 28.6* (22.6, 34.9) 1994-1999 87.2* (49.3, 134.8) 1999-2013 18.1* (12.6, 23.9) - - 
Slovenia 1995-2013 15.1* (9.4, 21.1) 1995-1999 82.3* (30.4, 154.9) 1999-2013 6.8* (1.6, 12.2) - - 
Spain 1994-2013 8.0* (5.9, 10.0) 1994-2002 18.4* (15.9, 21.1) 2002-2013 1.8* (0.4, 3.2) - - 
Sweden 1994-2013 13.5* (9.9, 17.3) 1994-1999 49.6* (33.7, 67.4) 1999-2013 6.7* (4.2, 9.2) - - 
United Kingdom 1994-2013 8.6* (7.2, 10.0) 1994-1999 6.0* (0.7, 11.6) 1999-2002 22.5 (-2.7, 54.2) 2002-2013 5.1* (3.5, 6.7) 
APC: Annual percent change; CI: Confidence intervals 
*p<0.05 for change in trend 
Table 3. Joinpoint analysis for Alzheimer’s disease mortality trends by European regions. 
 Total study period Period 1 Period 2 Period 3 
 Years APC (95% CI) Years APC (95% CI) Years APC (95% CI) Years APC (95% CI) 
Northern Europe 1994-2013 10.2* (9.0, 11.3) 1994-2002 15.0* (12.1, 18.0) 2002-2013 7.2* (5.5, 8.9) - - 
Eastern Europe 1994-2013 7.4* (6.4, 8.4) 1994-2005 9.5* (7.5, 11.5) 2005-2009 -0.8 (-13.2, 13.4) 2009-2013 15.0* (5.7, 25.2) 
Southern Europe 1994-2013 7.0* (5.2, 8.9) 1994-2004 13.5* (10.8, 16.3) 2004-2013 0.0 (-2.9, 2.9) - - 
Western Europe 1994-2013 3.4* (1.9, 5.0) 1994-2009 5.8* (4.7, 7.0) 2009-2013 -11.6* (-18.4, -4.2) - - 
APC: Annual percent change; CI: Confidence intervals 
*p<0.05 for change in trend 
 
Figure 1. Trends in mortality from Alzheimer’s disease in the European Union, 1994-2013 
Figure 1 legend  
Blue line: men 
Green line: women 
Red circle: men (age-standardised mortality rates) 
Blue cross: women (age-standardised mortality rates)
Supplemental table 1. Overall age-standardised mortality rates in the European Union, 1994-2013. 
Countries 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
European Union - - - - - - - - - - 28.18 31.01 31.41 34.10 35.78 39.20 40.03 41.86 45.45 45.19 
Austria 8.91 6.47 6.91 7.53 7.46 6.12 9.57 9.74 18.67 25.88 21.66 23.52 25.60 26.85 28.59 28.36 31.78 32.73 34.22 37.95 
Belgium - - - - 33.18 38.14 34.13 36.02 39.90 46.74 44.09 50.54 49.25 51.23 57.22 56.15 57.15 55.55 63.38 59.42 
Bulgaria - - - - - - - - - - - 2.93 3.23 4.56 5.67 5.52 5.38 6.30 8.42 5.86 
Croatia - 3.06 3.91 2.55 4.25 5.89 9.47 9.86 12.13 10.01 10.26 11.10 14.77 16.13 14.48 14.65 15.69 12.79 15.06 16.65 
Cyprus - - - - - - - - - - 24.99 22.55 34.72 36.62 40.07 38.19 36.77 37.35 49.27 41.27 
Czech Republic 13.30 11.14 10.82 14.16 17.23 18.02 20.05 23.98 24.21 27.23 28.61 31.59 34.86 17.72 19.20 13.53 13.53 34.75 39.64 40.63 
Denmark 5.98 9.33 8.19 10.63 12.79 14.25 16.38 21.09 24.16 25.69 30.52 33.72 36.37 40.93 40.93 41.36 49.17 50.05 49.40 53.35 
Estonia - - - 3.72 3.16 6.49 6.79 6.37 5.24 5.64 9.33 7.28 11.68 12.79 7.98 10.47 13.97 12.90 13.22 10.02 
Finland - - 37.75 45.42 48.31 48.53 52.26 60.51 78.25 84.37 96.43 108.23 129.76 149.05 165.35 192.87 218.10 233.03 260.96 278.92 
France 20.58 23.06 24.17 26.12 33.09 37.96 43.40 48.71 54.53 65.41 61.03 68.18 67.77 69.54 73.81 73.26 72.06 72.73 - - 
Germany - - - - 17.15 16.85 17.69 18.27 18.97 19.43 17.53 17.68 18.16 16.11 15.88 16.37 16.20 16.75 17.56 18.32 
Greece 1.45 2.20 2.55 4.45 4.98 6.40 9.39 9.59 8.29 7.57 9.57 7.30 8.13 8.11 5.99 6.97 6.17 5.30 8.65 6.54 
Hungary 1.36 1.46 3.37 2.91 3.69 3.84 4.76 5.11 4.61 4.80 5.82 6.65 6.93 7.21 8.16 7.96 9.44 10.15 11.51 11.46 
Ireland - - - 19.60 20.50 27.34 27.27 29.68 25.57 27.21 30.81 24.70 28.40 42.00 37.34 41.41 36.51 45.34 55.01 54.63 
Italy - - - - - - - 19.07 20.83 32.74 - - 31.97 35.46 37.21 37.71 37.18 38.25 39.77 36.90 
Latvia - - 1.78 1.93 4.91 2.22 4.69 7.12 6.87 4.05 2.87 3.63 3.85 4.96 4.85 4.17 3.93 3.61 4.57 4.72 
Lithuania 0.43 0.35 0.50 2.13 1.80 3.68 2.45 3.17 4.07 3.91 5.94 6.97 9.15 8.96 12.32 10.92 13.85 13.32 12.50 16.90 
Luxembourg - - - - 35.39 35.93 39.94 39.48 34.79 46.15 42.51 42.03 36.50 37.15 40.95 31.39 45.96 46.26 44.88 47.37 
Malta - 9.12 15.52 17.68 10.44 14.33 11.66 7.19 7.06 6.86 4.90 16.20 10.25 10.56 9.20 12.59 7.31 7.85 - 2.85 
Netherlands - - 15.94 18.50 15.96 18.16 17.47 18.74 21.74 22.17 21.40 23.35 26.36 26.84 31.68 33.88 37.84 40.42 45.24 72.06 
Poland - - - - - 11.61 11.88 13.46 13.76 13.75 15.87 17.76 17.88 16.81 17.26 18.39 19.08 19.86 19.81 20.41 
Portugal 5.39 5.88 8.55 10.37 11.20 16.56 19.86 - 28.70 39.06 36.16 40.32 36.91 41.29 41.23 42.96 43.94 41.34 42.41 40.49 
Romania - - - - - 1.48 1.99 2.86 3.29 5.85 7.70 8.29 9.97 11.85 12.16 12.39 20.03 23.95 26.20 27.07 
Slovakia 0.58 0.62 0.42 0.84 3.00 3.75 4.32 6.04 7.09 8.71 10.29 14.63 13.31 18.67 17.29 15.16 18.49 35.15 58.80 31.13 
Slovenia - 1.10 1.01 1.11 5.93 4.33 6.48 6.28 11.77 11.79 11.43 10.17 8.73 6.67 12.05 8.33 9.50 14.80 16.02 16.24 
Spain 17.35 19.94 21.19 23.48 27.85 42.57 44.10 50.16 53.22 63.42 59.26 64.35 63.06 65.66 66.07 68.30 66.58 67.08 70.96 67.47 
Sweden 4.47 5.64 6.17 17.11 16.66 21.90 23.45 30.21 31.76 35.12 39.77 40.95 43.79 46.50 46.19 46.78 51.46 50.56 59.47 58.17 
United Kingdom 10.20 12.56 13.09 12.97 14.42 14.49 14.11 27.52 29.00 29.95 28.63 28.52 28.33 32.21 34.61 33.62 35.94 40.15 46.99 49.84 
  
Supplemental table 2. Age-standardised mortality rates in men in the European Union, 1994-2013. 
Countries 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
European Union - - - - - - - - - - 26.36 28.48 28.57 30.77 32.10 34.84 35.18 36.80 39.40 39.45 
Austria 9.74 6.36 7.70 7.80 8.61 6.89 10.41 9.69 19.95 25.47 21.33 24.60 27.56 28.25 26.71 28.35 29.95 29.79 30.53 34.69 
Belgium - - - - 33.09 36.30 32.18 36.16 35.31 40.19 43.13 45.79 45.03 47.96 51.73 48.74 54.07 49.63 55.87 54.43 
Bulgaria - - - - - - - - - - - 2.57 2.91 5.73 5.41 5.50 5.57 5.39 7.78 5.60 
Croatia - 2.73 4.78 2.98 3.97 7.52 10.18 7.95 12.67 8.59 11.37 10.69 12.37 13.98 15.49 11.72 11.64 12.76 12.35 19.15 
Cyprus - - - - - - - - - - 25.86 26.78 27.82 43.21 29.13 37.24 27.28 25.61 41.27 49.40 
Czech Republic 11.61 10.09 7.79 10.07 13.17 16.08 17.46 22.04 22.47 23.57 27.65 27.85 31.97 16.95 21.28 12.51 13.18 35.39 41.89 39.31 
Denmark 7.09 10.03 8.41 12.09 11.35 14.55 17.34 20.08 19.35 25.67 26.67 30.47 34.81 39.44 39.05 38.65 43.40 47.56 42.79 48.29 
Estonia - - - 2.80 4.87 8.02 7.48 8.92 4.48 5.63 6.72 6.40 7.72 13.47 6.91 12.09 10.85 11.83 9.24 11.22 
Finland - - 36.56 40.57 45.93 43.20 49.42 64.82 81.65 84.24 100.46 119.54 139.32 159.14 175.22 196.00 219.90 225.24 254.24 270.02 
France 20.42 22.54 23.74 24.87 30.97 33.69 39.46 45.91 48.76 58.72 54.80 61.33 59.94 59.72 63.41 62.38 59.65 62.07 - - 
Germany - - - - 19.25 18.41 18.43 19.87 19.51 20.04 18.52 17.42 17.50 15.77 14.33 14.96 15.38 15.01 16.04 16.68 
Greece 1.46 2.19 2.17 4.73 5.17 5.93 10.10 8.96 8.29 6.91 8.10 6.75 6.93 7.64 4.74 4.92 4.89 5.00 7.05 4.64 
Hungary 1.47 1.30 3.31 2.44 3.71 3.77 4.58 5.18 5.48 4.61 5.64 6.48 6.75 7.96 8.17 8.44 10.02 12.31 12.47 13.70 
Ireland - - - 15.61 20.38 28.61 20.30 23.38 22.91 19.55 26.38 20.99 19.20 33.26 31.46 30.75 30.11 36.38 47.41 45.36 
Italy - - - - - - - 18.27 20.40 31.99 - - 30.26 33.75 34.57 35.44 34.36 34.82 36.10 34.23 
Latvia - - 1.19 0.69 2.26 0.38 2.38 4.01 3.99 1.81 2.35 3.20 4.22 8.36 3.77 3.76 2.80 2.97 3.64 3.92 
Lithuania 0.19 0.38 0.40 0.71 1.96 5.56 3.50 3.93 3.82 3.34 7.42 6.35 9.96 9.62 11.64 9.94 14.37 12.34 12.42 20.51 
Luxembourg - - - - 56.59 45.73 27.55 40.96 24.45 49.18 55.29 47.76 32.61 38.06 42.70 19.16 39.27 46.92 27.50 39.30 
Malta - 14.45 12.80 28.82 10.55 13.51 9.96 5.77 3.77 6.80 6.68 10.24 4.14 13.71 10.73 11.02 6.59 - - 2.77 
Netherlands - - 9.88 11.75 12.51 13.47 12.87 14.33 17.30 17.41 16.19 18.30 20.27 21.52 25.10 26.81 29.96 32.98 34.86 60.04 
Poland - - - - - 11.34 11.36 13.81 12.71 13.37 14.93 16.63 16.99 14.85 16.16 16.25 17.99 18.11 17.60 18.36 
Portugal 5.60 5.78 9.48 11.58 11.97 16.03 21.79 - 28.03 39.58 38.09 41.35 37.41 42.06 44.06 42.65 43.24 40.69 40.75 39.99 
Romania - - - - - 1.16 1.96 2.47 2.76 5.52 6.93 6.66 9.67 10.66 11.43 11.81 17.06 24.70 23.50 23.22 
Slovakia 1.08 1.01 0.45 1.33 2.27 2.27 4.26 7.37 6.62 8.80 9.37 14.11 15.89 20.13 17.14 14.83 17.74 32.25 54.88 29.32 
Slovenia - 1.62 2.05 0.35 8.20 3.25 8.75 7.70 16.86 18.09 14.34 9.72 8.70 9.89 16.60 10.17 9.50 11.13 15.32 10.68 
Spain 17.08 19.72 19.97 21.38 25.69 37.81 38.76 43.85 46.03 52.87 50.85 52.82 52.34 53.18 54.62 58.07 55.17 54.58 57.49 55.45 
Sweden 4.87 5.96 7.41 15.58 15.31 17.19 21.43 25.93 25.89 30.39 36.87 36.67 39.54 42.00 38.73 37.97 42.85 41.41 52.89 50.35 
United Kingdom 9.23 12.04 12.06 11.73 12.50 12.20 12.01 24.07 25.73 25.06 24.85 24.67 23.58 27.65 29.67 28.41 29.60 33.84 38.65 41.52 
 
Supplemental table 3. Age-standardised mortality rates in women in the European Union, 1994-2013. 
Countries 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
European Union - - - - - - - - - - 28.87 32.03 32.61 35.55 37.42 41.13 42.19 44.14 48.31 47.88 
Austria 8.61 6.52 6.51 7.55 6.94 5.81 9.05 9.97 18.26 25.86 21.75 22.88 24.63 26.16 29.83 27.59 32.64 33.61 35.78 39.60 
Belgium - - - - 33.03 38.89 34.86 35.91 41.91 49.18 43.80 52.01 51.20 52.85 59.70 59.72 58.11 58.35 67.00 62.06 
Bulgaria - - - - - - - - - - - 3.21 3.42 3.84 5.80 5.56 5.36 6.82 8.86 6.05 
Croatia - 3.22 3.57 2.37 4.48 5.18 9.24 10.63 11.93 10.87 10.07 11.13 15.91 16.58 14.15 16.05 17.49 12.86 16.18 15.68 
Cyprus - - - - - - - - - - 23.67 19.30 40.22 31.53 47.78 38.72 43.74 45.83 54.80 34.92 
Czech Republic 14.17 11.67 12.18 16.05 18.86 18.75 21.32 25.14 25.17 28.74 29.03 33.23 36.21 17.93 18.19 13.96 13.74 34.40 38.50 41.43 
Denmark 5.36 9.19 8.32 10.06 13.43 13.83 16.09 21.67 26.89 25.86 32.41 35.38 37.28 41.70 42.14 42.84 52.34 51.30 53.17 55.38 
Estonia - - - 4.32 2.91 5.28 7.53 5.62 5.68 5.40 10.43 7.57 12.73 13.20 8.48 10.19 15.80 14.12 14.55 10.02 
Finland - - 38.23 47.41 49.18 51.05 53.22 58.92 77.39 83.96 93.81 102.03 125.07 143.93 160.05 190.37 214.47 233.36 262.78 280.82 
France 20.52 23.12 24.28 26.48 33.91 39.85 45.01 49.60 57.02 68.12 63.37 70.67 71.01 73.83 78.49 78.11 77.64 77.40 - - 
Germany - - - - 16.23 16.09 17.21 17.43 18.60 19.02 16.83 17.52 18.16 15.95 16.42 16.79 16.33 17.26 18.11 18.85 
Greece 1.48 2.22 2.85 4.27 4.89 6.80 8.83 9.92 8.30 8.03 10.62 7.69 8.96 8.44 6.83 8.37 7.01 5.51 9.84 7.86 
Hungary 1.35 1.62 3.47 3.20 3.68 3.91 4.92 4.99 4.17 4.92 5.94 6.74 7.10 7.02 8.21 7.79 9.13 9.33 11.09 10.55 
Ireland - - - 21.37 20.39 25.66 30.54 32.95 27.38 31.06 33.07 26.58 32.88 46.38 39.77 47.11 39.32 50.47 59.13 60.19 
Italy - - - - - - - 19.48 21.03 33.03 - - 32.66 36.28 38.43 38.61 38.38 39.90 41.41 37.98 
Latvia - - 1.98 2.49 6.01 3.05 5.48 8.04 7.90 5.02 3.12 3.63 3.84 4.20 5.06 4.49 4.30 3.72 5.04 5.11 
Lithuania 0.60 0.30 0.51 2.92 1.73 2.92 1.89 2.87 4.17 4.17 5.60 7.16 8.96 8.67 12.80 11.20 13.45 13.85 12.75 15.50 
Luxembourg - - - - 24.51 30.50 44.44 38.69 38.12 45.17 38.21 38.92 39.04 36.63 39.84 38.12 48.27 44.23 51.21 50.72 
Malta - 6.32 16.97 12.02 11.29 14.16 12.17 7.59 9.10 6.40 3.96 19.98 13.59 8.61 8.01 13.59 7.43 - - 3.28 
Netherlands - - 18.57 21.27 17.18 19.99 19.21 20.71 23.62 24.19 23.44 25.45 29.31 29.14 34.59 37.00 41.39 43.87 50.09 77.67 
Poland - - - - - 11.70 12.11 13.25 14.28 13.89 16.48 18.28 18.27 17.73 17.90 19.44 19.69 20.71 20.89 21.45 
Portugal 5.18 5.65 7.89 9.44 10.62 16.83 18.60 - 28.82 38.81 34.72 39.36 36.49 40.44 39.36 42.81 44.03 41.28 43.05 40.55 
Romania - - - - - 1.67 2.02 3.06 3.62 5.97 8.08 9.22 10.10 12.46 12.51 12.63 21.57 23.51 27.64 29.02 
Slovakia 0.25 0.38 0.39 0.65 3.64 4.55 4.34 5.39 7.05 8.98 10.39 14.83 12.11 17.97 17.28 15.28 19.05 36.45 60.36 31.86 
Slovenia - 0.78 0.53 1.39 4.87 4.90 5.65 5.44 9.47 9.51 10.11 9.99 8.11 5.54 10.31 7.25 8.93 15.46 16.04 18.07 
Spain 17.45 19.98 21.80 24.53 28.90 44.97 46.73 53.36 57.01 68.55 63.40 69.99 68.31 71.82 71.75 73.31 72.46 73.39 77.97 73.57 
Sweden 4.17 5.44 5.33 18.11 17.65 24.68 24.86 32.50 35.15 38.00 41.32 43.41 46.11 48.78 50.32 52.11 56.31 55.83 63.57 62.84 
United Kingdom 10.69 12.80 13.59 13.56 15.17 15.51 15.18 29.23 30.37 32.38 30.47 30.48 30.65 34.62 37.17 36.53 39.33 43.65 51.75 54.78 
 
